Stay updated on Evobrutinib Study in RMS Patients Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib Study in RMS Patients Clinical Trial page.

Latest updates to the Evobrutinib Study in RMS Patients Clinical Trial page
- Check4 days agoChange DetectedA Locations section was added and Massachusetts listed as a site, with the previous Massachusetts Locations entry removed. The revision tag was updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer shows Revision: v3.3.2 replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page no longer displays a government funding lapse notice and NIH operating status information. All study content, including the details and eligibility criteria, remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedThe two screenshots show minor layout adjustments and small date/location updates within the Study Details page, with no changes to core content such as eligibility criteria, interventions, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, indicating a new version release.SummaryDifference0.1%

Stay in the know with updates to Evobrutinib Study in RMS Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib Study in RMS Patients Clinical Trial page.